Sakineh Khatoun Sharif

Sakineh Khatoun Sharif

Auto-generated profile, based on publicly available information

Sakineh Khatoun Sharif

Rheumatology Research Center, Tabriz University for Medical Sciences, Tabriz, Iran

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2014 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
BABeitullah Alipour
Beitullah Alipour
Aziz Homayouni-RadAziz Homayouni-Rad
Aziz Homayouni-Rad
EVElnaz Vaghef‐Mehrabany
Elnaz Vaghef‐Mehrabany
SSSakineh Khatoun Sharif
Sakineh Khatoun Sharif
LVLeila Vaghef‐Mehrabany
Leila Vaghef‐Mehrabany
JMJavad Mohtadi‐Nia
Javad Mohtadi‐Nia

9 April 2015 in Journal of the American College of Nutrition
Verified
Journal Article
Closed access
EVElnaz Vaghef-Mehrabany
Elnaz Vaghef-Mehrabany
Aziz Homayouni-RadAziz Homayouni-Rad
Aziz Homayouni-Rad
BABeitullah Alipour
Beitullah Alipour
SSSakineh-Khatoun Sharif
Sakineh-Khatoun Sharif
LVLeila Vaghef-Mehrabany
Leila Vaghef-Mehrabany
SASerour Alipour-Ajiry
Serour Alipour-Ajiry
Objective: Rheumatoid arthritis (RA) is an autoimmune inflammatory disease that causes great pain and disability and increasing oxidative stress in patients. The objective of the present study was to evaluate the effects of probiotics—live microorganisms with many health benefits, including antioxidant properties—on oxidative stress indices of patients with RA. This study is a secondary analysis from a previously published study Methods: In a randomized double-blind placebo-controlled clinical trial, 46 patients with RA were assigned to one of two groups; patients in the probiotic group received a daily capsule containing 108 colony forming units (CFUs) of Lactobacillus casei 01 (L. casei 01), while those in the placebo group took identical capsules containing maltodextrin, for 8 weeks. In the baseline and at the end of the study, anxiety, physical activity levels, and dietary intakes were assessed. Anthropometric parameters, serum malondialdehyde (MDA), total antioxidant capacity (TAC), erythrocyte superoxide dismutase (SOD), glutathione peroxidase (GPx), and catalase (CAT) activities were measured. Results: There was no significant difference between the two groups for demographic characteristics, anthropometric parameters, physical activity, anxiety levels, or dietary intakes, throughout the course of the study. No significant within- and between-group differences were observed for MDA, TAC, or CAT. SOD activity decreased only in the probiotic group and GPx activity decreased in both study groups (p < 0.05); however, no significant between-group difference was found for these enzymes activities at the end of the study (p > 0.05). Conclusion: No significant effect of L. casei 01 supplementation was observed on the oxidative status of patients with RA, compared to placebo.

29 April 2012 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
AKAlireza Khabbazi
Alireza Khabbazi
MHMehrzad Hajialiloo
Mehrzad Hajialiloo
SKSousan Kolahi
Sousan Kolahi
MSMohsen Soroosh
Mohsen Soroosh
KEKamal Esalatmanesh
Kamal Esalatmanesh
SSSakinehkhatoon Sharif
Sakinehkhatoon Sharif

30 May 2011 in Scandinavian Journal of Rheumatology
Verified
Journal Article
Closed access
MEM Esmaeili
M Esmaeili
MBMortaza Bonyadi
Mortaza Bonyadi
AKA Khabbazi
A Khabbazi
AEAa Ebrahimi
Aa Ebrahimi
SSS-K Sharif
S-K Sharif
SDS Dastgiri
S Dastgiri
Objective: Behçet's disease (BD) is an inflammatory disorder of unknown cause with higher prevalence along the ancient Silk Road. BD shares epidemiological and clinical features with familial Mediterranean fever (FMF). Moreover, association of BD and certain MEFV gene mutations has been described in recent decades. We studied the role of MEFV mutations in Iranian Azeri Turkish patients with BD. Methods: Fifty-three BD patients who met the International Study Group criteria for BD were analysed for five common MEFV mutations (M694V, V726A, M680I, M694I, and E148Q) using amplification refractory mutation system and polymerase chain reaction (PCR) restriction–digestion testing methods. A cohort of 200 healthy Azeri Turkish individuals who had been previously genotyped regarding the five common MEFV mutations served as the control group. Results: Eighteen patients were found to carry a single MEFV mutation and one additional patient was compound heterozygote. There was a statistically significant difference between the patient group and ethnically matched healthy individuals regarding M694V and M680I mutations (p = 0.01 and p = 0.04, respectively). Both BD groups (carriers and non-carriers of MEFV mutations) were similar in their clinical symptoms. Conclusion: Definite MEFV mutations seem to be a susceptibility factor for BD in our cohort of Iranian Azeri Turkish patients.

1 January 1999 in Nephrology Dialysis Transplantation
Verified
Journal Article
Open access
PDF file
AYA Yoshimura
A Yoshimura
SUS Uda
S Uda
KIK Inui
K Inui
TNT Nemoto
T Nemoto
YSY Sugenoya
Y Sugenoya
TIT Ideura
T Ideura
Bcl-2 may account in part for the maintenance of hypercellularity in human glomerular diseases through preventing cell death and by counteracting bax which may be expressed to regulate excessive proliferation. This process is associated with the effect of PDGF B-chain expression. Bax expression may be important in the cell loss leading to glomerulosclerosis and TGF-beta1 participates in this process by increasing bax expression. Thus, the balance of bcl-2/bax expression may be critical in the course of human glomerular diseases.

15 May 2007 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
SSSakineh‐Khatoun Sharif
Sakineh‐Khatoun Sharif
SEShahin Eghbal
Shahin Eghbal
FGFarhad Gharibdoost
Farhad Gharibdoost
MKMahmood A. Kbarian
Mahmood A. Kbarian
FSFarhad Shahram
Farhad Shahram
FDFereydoun Davatchi
Fereydoun Davatchi